Obesity drug could cost $3 monthly
Generic semaglutide could transform access in 160 countries
- Semaglutide (Ozempic, Wegovy) could be made for $3 per month
- Over 1 billion people worldwide live with obesity
- Could help 160 countries once patents expire
- Obesity rates rising fastest in lower-income nations
- Affordable generics could transform global health access
More Stories
